WallStreetZenWallStreetZen

How to Buy Spyre Therapeutics Stock

Spyre Therapeutics Inc

Aeglea BioTherapeutics, Inc. , a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases.

Spyre Therapeutics stock last closed at $19.86, down 1.93% from the previous day, and has increased 81.87% in one year. It has overperformed other stocks in the Biotechnology industry by 1.06 percentage points. Spyre Therapeutics stock is currently +646.62% from its 52-week low of $2.66, and -17.25% from its 52-week high of $24.00.

At the moment, there are 4.05M SYRE shares outstanding. The market capitalization of SYRE is $80.41M. In the last 24 hours, 466,586 SYRE shares were traded.

How to Buy Spyre Therapeutics Stock

Wondering how to invest in Spyre Therapeutics stock? Here's how.
  1. Choose where to buy Spyre Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you figure out where to buy Spyre Therapeutics stock.
  2. Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
  3. Fund your brokerage account: Pick your method of payment and add your info.
  4. Analyze Spyre Therapeutics stock: The Spyre Therapeutics ticker symbol is SYRE. Is Spyre Therapeutics stock a good investment? Should you buy shares of SYRE? How do SYRE's underlying business fundamentals look? Do top analysts think Spyre Therapeutics is a good buy? Why has SYRE's stock price moved recently? (Hint: Our stock market research tools can help you decide if SYRE is a good stock to buy).
  5. Make your SYRE buy order: Decide if you will purchase SYRE shares at the current market price or use a limit order to buy SYRE shares at a given price.
  6. Get notifications regarding your SYRE position: Create a watchlist to important updates regarding your new investment in Spyre Therapeutics shares.

Step 1: Choose where to buy Spyre Therapeutics stock

You will need an online brokerage account to access the NASDAQ market and buy SYRE shares.

A brokerage account allows you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our research, eToro is the best online stock brokerage. Here's why:

  • You can invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to global markets: From Tech to Healthcare, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading exchanges.
  • Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by opening an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've chosen the best brokerage, you'll need to fill out some personal info so you are able to buy SYRE today.

How to Create a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal details to create a new brokerage account.
  1. Send your application by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you have filled out your info on the best free stock trading app, you need to deposit funds:

Watch the tutorial below to see the process of transferring funds into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Spyre Therapeutics stock

Once you have decided on the best place to buy Spyre Therapeutics stock, it's crucial to research their stock before you buy, so you truly understand the risk as well as the opportunity.

Spyre Therapeutics stock at a glance

SYRE Price
$19.86
1w %
6.43%
1y %
81.87%
5y %
-89.91%
P/E
-0.26x
P/B
-0.33x
P/S
81.06x
PEG
N/A
Revenue
$1.05M
Earnings
-$294.43M
Fore. Rev. Growth
-14.61%
Fore. Earn. Growth
N/A
Market Cap
$80.41M
Next Earnings
N/A
Next Dividend
N/A

SYRE Zen Score

WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis quickly.

You can view all of the due diligence checks on SYRE's stock page.

Is SYRE stock overvalued?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge SYRE's fair value.

You can do additional valuation analysis on SYRE's stock here.

SYRE Financial Health Summary

Pros:

  • There are more short-term assets than short-term liabilities on the SYRE balance sheet.
  • There are more short-term assets than long-term liabilities on the SYRE balance sheet.
  • SYRE has cash burn of 86539000. It has sufficient cash and short-term investments to cover this for at least one year.
  • SYRE has $204.91M in cash and short term investments. This is sufficient to cover its annual cash burn of $86.54M.

Cons:

  • SYRE profit margin has gone down from -1,471.8% to -27,934.7% in the past year.
  • Total SYRE debt is still negative.
  • SYRE debt to equity ratio of -0.27 is negative.

Is Spyre Therapeutics stock a Buy, Hold, or Sell, according to analysts?

Out of 2 Equities analysts who research SYRE, the consensus analyst rating on Spyre Therapeutics is a Buy

It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.

You can dig deeper into what analysts are forecasting on the Spyre Therapeutics stock forecast page.

SYRE Technicals

SMA10
17.14
SMA20
13.66
SMA50
12.52
SMA100
12.9
SMA200
9.84
MACD
2.36
MACD Signal
1.4
MACD Histogram
0.96
RSI
76.75
Stochastic %K
84.65
Stochastic %D
85.74
StochRSI %K
94.51
StochRSI %D
96.52

SYRE Revenue

Last year, SYRE revenue was $1.05M. Over the last 5 year, SYRE's revenue has grown by -27.79% per year. This was slower than the Biotechnology industry average of 37.38%.

You can analyze SYRE's earnings and revenue performance here.

Latest Insiders Trades at SYRE

Over the last year, insiders at SYRE have not bought or sold any shares.

Dig into more about who owns SYRE stock here.

Can I get consistent income from SYRE stock?

No, Spyre Therapeutics doesn't provide an income stream by paying out dividends.

SYRE Social Trading Data

One of the reasons eToro is our favorite brokerage is because of its social trading community.

Click below to see what other community members have to say.

Step 5: Make your SYRE buy order

You have two main options:

  • Market order: A market order is an order to buy or sell a security at the best available price.
    Market orders are generally sufficient.
  • Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at a given dollar amount, use a limit order.

Hit the Open button and eToro will place your order.

If you need additional help with investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get notifications regarding your SYRE position

Now that you own some shares in SYRE, you'll want to stay up-to-date on your new investment.

Create a watchlist to keep track of your SYRE stock.

SYRE Feed

How to Buy Stock in Spyre Therapeutics

To summarize, here are the 6 steps you need to take to buy Spyre Therapeutics stock right now:

  1. Choose where to buy Spyre Therapeutics stock
  2. Open your brokerage account
  3. Fund your brokerage account
  4. Analyze Spyre Therapeutics stock
  5. Make your SYRE buy order
  6. Get notifications regarding your SYRE position

If you need a online brokerage, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to keep track of your investment in Spyre Therapeutics, click the button below.

NASDAQ: SYRE
$19.86-0.39 (-1.93%)
Updated Dec 7, 2023
Open eToro Account
NASDAQ: SYRE
$19.86-0.39 (-1.93%)
Updated Dec 7, 2023
Open eToro Account

FAQ

How much does it cost to buy one Spyre Therapeutics share?

As of Dec 7, 2023, it costs $19.86 to buy one share of Spyre Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $9, you can buy 0.453 shares of SYRE.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Spyre Therapeutics stock?

According to 2 Wall Street analysts who monitor Spyre Therapeutics, their consensus recommendation is to buy Spyre Therapeutics stock.

What is the best way to buy Spyre Therapeutics stock?

One way to place an order for Spyre Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.